Learn why the FDA is asking to update testosterone replacement therapy labels after a major review of new evidence.
The disclosure comes after Celsius and other energy drink manufacturers face mounting scrutiny for allegedly failing to ...
Following a massive 162 percent surge in prescriptions and a major FDA label reversal, a critical shortage of estradiol ...
Zacks Investment Research on MSN
FDA expands IONS' Tryngolza label to treat severe hypertriglyceridemia
Ionis Pharmaceuticals IONS announced that the FDA has approved its wholly owned drug, Tryngolza (olezarsen), for a new ...
Second, the changes would ease longstanding warnings about the use of the hormone therapy in those with prostate cancer.
MedPage Today on MSN
FDA expands risankizumab label in psoriatic disease
IL-23 inhibitor lands indications for kids 6 years and up ...
The FDA announced it has approved two new drugs to expand treatment options for menopausal symptoms. (HHS) The Food and Drug Administration (FDA) will remove broad “black box” warning labels from ...
After 35 years of research and development in pharmaceutical products, Ionis began marketing its drugs for the first time in ...
Pfizer (PFE) stock is in focus as the FDA approves a label expansion therapy for breast cancer therapy, palbociclib, marketed ...
The US Food and Drug Administration (FDA) on Friday released draft guidance describing the process for drug companies when they have to update a generic’s label after the reference product (for which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results